Overview

Efficacy, Tolerability and Handling of Daivobet® Gel in Patients With Psoriasis Vulgaris

Status:
Completed
Trial end date:
2012-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this observational study is to evaluate the efficacy, tolerability, quality of life and handling of Daivobet® Gel by both physician and patient in daily practise.
Details
Lead Sponsor:
LEO Pharma
Collaborator:
LEO Pharma GmbH, Neu-Isenburg, Germany
Treatments:
Betamethasone
Calcitriol